Nitrofurantoin as a preferred first-line therapy for urinary tract infection: A comparison using urinary tract infection-specific antibiograms
Bladder · 2025
DOI: 10.14440/bladder.0018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bladder, 2025. Verfasst von Colby P Souders und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, United States of America. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Background
Local antibiograms are a highly useful tool to guide empiric antibiotic therapy for a variety of infections.
Objectives
This study compares nitrofurantoin (NF) susceptibility in outpatient urine isolates using antibiogram data from two United States academic medical centers.
Methods
In this brief report, we compare antibiograms of urinary isolates from two distinct academic institutions—the University of Texas Southwestern (UTSW) in Dallas, Texas, and the University of Kansas Medical Center (KU) in Kansas City, Kansas—focusing on the most common uropathogens susceptible to NF to evaluate whether NF remains an appropriate first-line agent for uncomplicated cystitis.
Results
For the 2022 antibiogram, KU tested 5,524 urinary isolates and UTSW tested 2,530 urinary isolates. The susceptibility data were consistent across the two institutions, suggesting that NF can continue to be considered a first-line therapy for uncomplicated urinary tract infections in women.
Conclusion
This report highlights the importance of clinicians consulting their local antibiograms to inform empiric antibiotic therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, School of Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, United States of America.
- Department of Pathology, School of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America.
- Department of Infectious Disease, School of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America.
- Department of Urology, School of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States of America.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Souders, C. P., Clark, A., Prokesch, B. C., & Zimmern, P. E. (2025). Nitrofurantoin as a preferred first-line therapy for urinary tract infection: A comparison using urinary tract infection-specific antibiograms. Bladder. https://doi.org/10.14440/bladder.0018
Vancouver
Souders CP, Clark A, Prokesch BC, Zimmern PE. Nitrofurantoin as a preferred first-line therapy for urinary tract infection: A comparison using urinary tract infection-specific antibiograms. Bladder. 2025. doi:10.14440/bladder.0018
BibTeX
@article{Souders2025,
author = {Souders, Colby P and Clark, Andrew and Prokesch, Bonnie C and Zimmern, Philippe E},
title = {Nitrofurantoin as a preferred first-line therapy for urinary tract infection: A comparison using urinary tract infection-specific antibiograms},
journal = {Bladder},
year = {2025},
doi = {10.14440/bladder.0018}
}
EUVIMED